|
2025
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of neutrophil-mediated diseases and ... |
|
2024
|
P/S
|
Computational design and molecular engineering of therapeutic proteins for medical use |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of kidney diseases and conditions; P... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of pulmonary diseases and conditions... |
|
|
Invention
|
Methods for treating pulmonary non-tuberculous mycobacterial infections.
Provided herein are met... |
|
|
P/S
|
Medical services, namely, providing medical advice to
patients regarding administration and use ... |
|
|
Invention
|
Novel igg proteases and methods of use thereof. Provided herein are novel immunoglobulin G (IgG) ... |
|
|
Invention
|
Systems for treating pulmonary infections.
Provided herein are systems for treating a subject wi... |
|
|
Invention
|
Uricase variants and methods of use thereof. The present disclosure relates to uricase variants a... |
|
|
Invention
|
Novel uricase variants and methods of use thereof. Arthrobacter globiformis , Aspergillus flavus ... |
|
|
Invention
|
Nannochloropsis-producing viruses and methods and compositions for making the same. Nannochlorops... |
|
|
P/S
|
Medical services, namely, providing medical advice to patients regarding administration and use o... |
|
|
Invention
|
Spray dried treprostinil formulation. The present disclosure provides aerosol properties of a pow... |
|
|
Invention
|
Dpp1 inhibitors with polycyclic linkers and uses thereof. Provided herein are compounds of Formul... |
|
|
Invention
|
Uses of certain 1,4-oxazepane-2-carboxamides as dpp1 inhibitors. Provided herein are compositions... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention
of neutrophil-mediated diseases and... |
|
|
Invention
|
Novel, reversible dpp1 inhibitors and uses thereof. Provided herein are compounds of Formula (I),... |
|
2023
|
P/S
|
Pharmaceutical preparations, namely, protein and peptide
preparations for use in human medicine;... |
|
|
Invention
|
Uricase conjugates and methods of use thereof. The present invention provides novel uricase conju... |
|
|
Invention
|
Prostacyclin compounds, compositions and methods of use thereof.
Prostacyclin compounds and comp... |
|
|
Invention
|
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiecta... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of sarcoidosis, interstitial lung disease, pulmonar... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of
sarcoidosis, interstitial lung disease, pulmona... |
|
|
Invention
|
Dry powder compositions of treprostinil prodrugs and methods of use thereof. The present disclosu... |
|
|
Invention
|
Novel dpp1 inhibitors and uses thereof. Provided herein are novel DPP1 inhibitor compounds having... |
|
|
P/S
|
Proteins, namely, algae cells for use in the manufacture of biologic medicines, namely, protein t... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cardiac muscle disorders and diseases; pharmaceu... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cardiac
muscle disorders and diseases; pharmace... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of lung infections and pulmonary diseases. Medical ... |
|
|
P/S
|
Arranging and conducting of conferences and congresses in the field of medicine, pharmaceuticals ... |
|
|
Invention
|
Methods of manufacturing treprostinil and treprostinil derivative prodrugs.
Methods for making p... |
|
|
Invention
|
Certain n-(1-cyano-2-phenylethyl)-1,4-oxazepane-2-carboxamides for treating hidradenitis suppurat... |
|
|
Invention
|
Dry powder compositions of bedaquiline and salts and methods of use thereof. The present disclosu... |
|
2022
|
Invention
|
Methods for continuous manufacture of liposomal drug products.
Provided herein are methods for m... |
|
|
Invention
|
Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use t... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cardiac muscle disorders and diseases; Pharmaceu... |
|
|
Invention
|
Certain n-(1-cyan0-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating chronic rhinosinusiti... |
|
|
Invention
|
Certain n-(1-cyano-2-phenylethyl)-1,4-oxazepane-2-carboxamides for treating chronic rhinosinusiti... |
|
|
P/S
|
Educational services, namely, conducting seminars, non-downloadable webinars, conferences, progra... |
|
|
Invention
|
Sustained release of antiinfectives.
Provided are lipid antiinfective formulations substantially... |
|
|
Invention
|
Tunable polymeric nanoparticles for targeted and sustained delivery of glycopeptide antibiotics. ... |
|
|
Invention
|
Methods for treating pulmonary non-tuberculous mycobacterial infections. Provided herein are meth... |
|
|
Invention
|
Adeno-associated virus particles and methods of use thereof.
The invention provides intrathecal ... |
|
|
Invention
|
Adeno-associated virus particles and methods of use thereof. The invention provides intrathecal c... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of rare and orphan diseases, namely, Stargardt dise... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of rare
diseases; pharmaceutical preparations for ... |
|
|
Invention
|
In vitro release assay methods for liposomal aminoglycoside formulations.
The present disclosure... |
|
|
Invention
|
In vitro release assay methods for liposomal aminoglycoside formulations. in vitroin vitro releas... |
|
|
Invention
|
Certain n-(1-cyano-2-phenylethyl)-1,4-oxazepane-2-carboxamides for treating cystic fibrosis.
The... |
|
|
Invention
|
Certain n-(1-cyano-2-phenylethyl)-1,4-oxazepane-2-carboxamides for treating cystic fibrosis. The ... |
|
|
Invention
|
N-(1-cyano-2-phenylethyl)-1,4-oxazepane-2-carboxamides for treating cystic fibrosis. NN-(1-cyano-... |
|
|
Invention
|
Certain n-(1-cyano-2-phenylethyl)-1,4-oxazepane-2-carboxamides for treating cancer. NSNSS)-1-cyan... |
|
|
Invention
|
Combination therapy for treating non-tuberculous mycobacterial lung disease. Provided herein are ... |
|
|
Invention
|
Dry powder compositions of glycopeptide derivative compounds and methods of use thereof. The pres... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparatio... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of rare pulmonary and rare neuromuscular diseases; ... |
|
2021
|
Invention
|
Certain (25)-iv-[(ls')~ i-c yan0-2-phenylethyl·]- 1,4-oxazepane-2- carboxamides for treating behc... |
|
|
Invention
|
Dry powder compositions of treprostinil prodrugs and methods of use thereof.
The present disclos... |
|
|
P/S
|
medical devices, namely, nebulizers |
|
|
Invention
|
Methods for treating newly diagnosed mycobacterium avium complex lung infections.
Provided is a ... |
|
|
Invention
|
Methods for extracting neutrophil serine proteases and treating dipeptidyl peptidase 1-mediated c... |
|
|
Invention
|
Pharmaceutical formulations of treprostinil prodrugs and methods of use thereof.
The present dis... |
|
2020
|
P/S
|
Educational services, namely, providing online education, instruction and training in the field o... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of infectious diseases. |
|
2019
|
P/S
|
Providing on-line magazines in the field of pharmaceutical preparations, medical research and tre... |
|
|
P/S
|
pharmaceutical preparations for the treatment of pulmonary diseases. |
|
2018
|
P/S
|
Retail store services in relation to pharmaceutical preparations; advertising relating to pharmac... |
